$47.18
▲ +0.5% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
Tempus makes $1.5B bet to corner cancer-test market
Tempus AI (TEM) On Its Personalis Deal And Whether The Bull Case Is Priced In
Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion
Overview
52-week range
$42
$104
9% of range
Avg surprise (last 3)
+27.7%
Avg reaction (last 2)
-3.3%
0% positive
Latest IV / EM
94%
EM ±11.8% · $47 · Jul 31
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-0.37 | $-0.47 | +21.3% | -27.6% | -3.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.46 | — | — | — | — | financials |
| Fri Aug 8, 2025 | Jun/2025 | $-0.36 | $-0.47 | +23.4% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $-0.29 | $-0.47 | +38.3% | — | -3.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.46 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-6.86 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.47 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.03 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.07 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | AMC | -$0.41 | -$0.36 | -13.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $348M | — | $334M | $315M | $256M | — | $181M | $166M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-85M | — | $-61M | $-62M | $-69M | — | $-54M | $-533M |
| Net income | $-126M | — | $-80M | $-43M | $-68M | — | $-76M | $-552M |
| EPS (diluted) | $-0.71 | — | $-0.46 | $-0.25 | $-0.40 | — | $-0.46 | $-6.86 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $521M | $605M | $656M | $186M | $152M | $341M | $388M | $479M |
| Inventory | $52M | $52M | $55M | $48M | $50M | $38M | $36M | $33M |
| Total current assets | $1.05B | $1.17B | $1.15B | $644M | $574M | $668M | $679M | $671M |
| Total assets | $2.14B | $2.27B | $2.28B | $1.63B | $1.54B | $926M | $972M | $865M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1.72B | $1.78B | $1.77B | $1.32B | $1.22B | $870M | $918M | $766M |
| Total equity | $416M | $491M | $508M | $310M | $326M | $56M | $54M | $98M |